Literature DB >> 27930749

Exploitation of the Host Cell Membrane Fusion Machinery by Leishmania Is Part of the Infection Process.

Christine Matte1, Albert Descoteaux1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27930749      PMCID: PMC5145244          DOI: 10.1371/journal.ppat.1005962

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


× No keyword cloud information.
Successful vacuolar pathogens have developed sophisticated strategies to hijack the endomembrane system of host cells, sabotage their signal transduction pathways, and evade antimicrobial responses. The protozoan parasite Leishmania, the causative agent of leishmaniases in humans, is particularly adept at transforming the macrophage into a hospitable host cell. Here, we describe how Leishmania promastigotes subvert the macrophage membrane fusion machinery to create an intracellular compartment favorable to the establishment of infection and to manipulate host immune responses.

What Is the Membrane Fusion Machinery?

Cellular functions such as phagocytosis and cytokine secretion rely heavily on a complex network of vesicle trafficking pathways that interconnect most membrane-bound intracellular compartments [1]. A critical step in the exchange of cargoes between vesicles in this network is the process of membrane fusion, which is mediated by SNARE (soluble -ethylmaleimide-sensitive factor attachment protein receptor) proteins. This superfamily of integral and peripheral membrane proteins displays the distinctive SNARE motif, a stretch of heptad repeats that form a coiled-coil structure with a conserved arginine (R) or glutamine (Q) residue at the central “0” layer. Fusogenic SNARE complex formation requires the parallel association of an R-SNARE domain on the vesicle membrane with three cognate Q-SNARE domains on the target compartment. The subsequent “zippering” of this four-helix bundle from the membrane-distal amino termini towards the membrane-proximal carboxyl termini brings the two apposed membranes into close proximity and provides sufficient mechanical force to overcome the energy barrier for the formation of the fusion pore [1]. Whereas SNAREs make up the core of membrane fusion machinery, a large number of additional proteins are required for the spatiotemporal orchestration of the entire process [2]. For instance, the family of Rab GTPases are master regulators of virtually all events leading to membrane fusion. Indeed, Rab effectors include motor proteins (for vesicle trafficking along the cytoskeleton) and membrane tethers (for the initial, loose attachment to the target compartment). A set of chaperones, such as the proteins of the Sec1/Munc18 (SM) family, Munc13 and Complexins, oversee the timing of cognate SNARE pairing by restricting SNARE accessibility at first, then initiating partial SNARE complex formation and keeping it in a “release-ready” state until the appropriate moment for membrane fusion. The final trigger for pore formation is provided by synaptotagmins (Syts), a family of calcium-sensing membrane proteins that control fusion via interactions with SNARE proteins and membrane lipids. Ultimately, SNARE complexes are disassembled by the ATPase NSF (-ethylmaleimide-sensitive factor) and the adaptor protein α-SNAP (soluble NSF attachment protein).

What Is the Role of Vesicle Trafficking and Membrane Fusion during the Phagocytic Process?

Binding and internalization of infective Leishmania stages to macrophages involves multiple phagocytic receptors [3]. Phagocytosis of those large particles requires the expense of a considerable amount of plasma membrane for pseudopod extension around the prey. Various membrane-bound intracellular compartments lend a hand to this process by fusing with the cell surface and rapidly providing endomembrane required for particle engulfment [4]. Focal exocytosis of recycling endosomes, for instance, contributes not only to phagocytosis but also allows for rapid secretion of preformed inflammatory cytokines including TNF and IL-6 [5]. Fusion of recycling endosomes with the cell surface is mediated by the R-SNARE VAMP3 (vesicle-associated membrane protein 3) [1, 4] and is regulated by Syt V [6]. Interestingly, Syt XI also localizes to recycling endosomes and is recruited to nascent phagosomes, but acts as a negative regulator of phagocytosis and cytokine secretion [7]. Late endosomes and lysosomes assist large particle phagocytosis as well, in a VAMP7- and Syt VII-dependent manner [1, 4, 8]. Contribution of the endoplasmic reticulum (ER) as a source of endomembrane varies according to the nature of the phagocytosed particle and requires the ER Q-SNARE Stx18 [4, 9]. Upon the completion of particle internalization, the phagosome undergoes a series of “kiss-and-run” fusion and fission events with vesicles of the endocytic pathway, culminating in the creation of a highly microbicidal and immunologically competent compartment, the phagolysosome. Various components of the membrane fusion machinery participate in the genesis of this organelle, including the endosomal R-SNARE VAMP8 for the recruitment of the NADPH oxidase NOX2 [10], Syt V for the acquisition of the v-ATPase (vesicular proton-ATPase) [11], and the ER R-SNARE Sec22b for the recruitment of ER components required for antigen crosspresentation [12].

Do Leishmania Parasites Disrupt the Membrane Fusion Machinery to Tamper with Macrophage Responses?

Pathogens use a variety of tactics to manipulate membrane fusion and vesicle trafficking to cause disease [13]. The intracellular bacteria Chlamydia and Legionella, for instance, produce proteins with SNARE-like motifs that interact with host SNAREs and inhibit SNARE-mediated membrane fusion. The best-known example is the specific cleavage of SNAREs by clostridial neurotoxins, which are potent blockers of neurotransmission in peripheral cholinergic nervous system synapses [14]. Leishmania promastigotes use two abundant surface GPI-anchored virulence factors to interfere with vesicle trafficking and fusion: GP63 (glycoprotein 63), a zinc-dependent metalloprotease, and LPG (lipophosphoglycan), a polymer of repeating Galβ1,4Manα1-PO4 units. Upon internalization of the parasites, GP63 and LPG are rapidly redistributed throughout infected cells (Fig 1). Akin to the clostridial neurotoxins, GP63 cleaves components of the host cell membrane fusion machinery, including VAMP3, VAMP8, and Syt XI (Table 1) [10, 15]. The consequences of these cleavage events are diverse. In macrophages and dendritic cells, processing of exogenous antigens for crosspresentation on MHC I molecules is controlled by the NADPH oxidase NOX2: phagosome oxidation prevents excessive acidification and destruction of peptides destined for recognition by T cells [16]. Since VAMP8 is involved in the recruitment of NOX2 to phagosomes, GP63-mediated cleavage of VAMP8 results in increased phagosomal proteolytic activity, ensuing in defective crosspresentation of Leishmania antigens to T cells [10]. In parallel, during a noncanonical autophagic process referred to as LC3-associated phagocytosis (LAP), NOX2-mediated phagosomal oxidation promotes the recruitment of the autophagy-related protein LC3 to a subset of phagosomes. Several roles have been attributed to LAP, including increased phagosomal microbicidal activity and enhanced antigen presentation on MHC II molecules [17]. By cleaving VAMP8 and preventing phagosomal recruitment of NOX2, GP63 allows Leishmania major promastigotes to evade LAP [18], possibly contributing to the impairment of phagosome maturation and further inhibiting antigen presentation to T cells. Consistent with the role of Syt XI as a negative regulator of cytokine secretion, cleavage of this endosomal protein by GP63 from L. major promastigotes increases the postinfection release of TNF and IL-6 [15]. These proinflammatory cytokines are responsible for the augmentation of neutrophil and inflammatory monocyte influx to the parasite inoculation site, which contributes to the spread and maintenance of infection.
Fig 1

Distribution of L. major virulence factors LPG and GP63 across an infected macrophage.

Murine primary macrophages were infected for 6 h with L. major promastigotes, fixed and stained for confocal immunofluorescence microscopy using DAPI (DNA, blue) and antibodies against LPG (red) and GP63 (green). Arrowheads point to parasite nuclei. Scale bar = 5 μm.

Table 1

Components of the host cell membrane fusion machinery targeted by Leishmania parasites.

Subcellular localization and function in macrophages of each host protein are indicated.

Targeted host proteinSubcellular localizationFunctionsModificationParasite factor involvedRef.
VAMP3Recycling endosomesFocal exocytosis of recycling endosomesProteolyic cleavageGP63[10]
Cytokine secretion
VAMP8Late endosomes and lysosomesRecruitment of NOX2Proteolyic cleavageGP63[10, 18]
Crosspresentation
LC3-associated phagocytosis
Syt VRecycling endosomesFocal exocytosis of recycling endosomesExclusion from the phagosomeLPG[11]
Recruitment of vATPase
Syt XIRecycling endosomesNegative regulator of cytokine secretion and phagocytosisProteolyic cleavageGP63[15]

Distribution of L. major virulence factors LPG and GP63 across an infected macrophage.

Murine primary macrophages were infected for 6 h with L. major promastigotes, fixed and stained for confocal immunofluorescence microscopy using DAPI (DNA, blue) and antibodies against LPG (red) and GP63 (green). Arrowheads point to parasite nuclei. Scale bar = 5 μm.

Components of the host cell membrane fusion machinery targeted by Leishmania parasites.

Subcellular localization and function in macrophages of each host protein are indicated. Insertion of LPG into host cell lipid microdomains causes remodeling of the phagosome and delays its maturation into a highly microbicidal phagolysosome, as a result of reduced fusogenicity towards late endosomes and lysosomes [19]. The current model of LPG-mediated phagosome remodeling is that LPG disrupts membrane lipid microdomains and thereby interferes with the clustering of host molecules at these sites [19]. For instance, SNAREs and other members of the membrane fusion machinery are typically concentrated in cholesterol-rich membrane rafts [1]. Therefore, one consequence of LPG-mediated microdomain disorganization is the exclusion of Syt V from the phagosome (Table 1). This, in turn, abrogates v-ATPase recruitment and impedes phagosome acidification [11]. Aside from GP63-mediated cleavage and LPG-induced phagosomal exclusion of SNAREs and Syts, Leishmania parasites also target components of the membrane fusion machinery at the transcriptional level. Infection of human macrophages with L. major or L. amazonensis leads to the up-regulation of Syt II, VI, and VIII [20]. The underlying mechanism, including the parasite factors and/or host proteins involved, and the repercussions on PV (parasitophorous vacuole) formation and infection outcome have yet to be uncovered. Of note, the genome of L. major encodes a repertoire of 27 putative SNARE proteins, which can be segregated into R-SNAREs and Q-SNAREs based on the classification system used for other organisms. Most of these proteins display the expected structural characteristics of functional SNAREs, while a few show peculiarities. For instance, four proteins lack a predicted transmembrane domain or GPI-anchor, and only two out of the four possess potential lipidation sites for attachment to membranes [21]. Whether any of these 27 putative SNAREs play a role in the manipulation of host cell fusion events by Leishmania parasites is unknown.

Do Leishmania Parasites Promote Vesicle Fusion to Drive PV Formation?

Old World Leishmania species (L. major, L. donovani, and L. tropica) reside in small, tight-fitting PVs that undergo fission shortly after parasite replication, therefore rarely containing more than a single amastigote. On the other hand, the establishment of a successful infection by New World species (L. mexicana, L. amazonensis, and L. pifanoi) requires the formation of spacious, communal vacuoles that can harbour numerous parasites. Our understanding of the mechanisms allowing the development of individual versus communal PVs is very limited. Both types of PVs continuously interact with the host cell reservoir of acidic [22] and ER-derived vesicles [23], most likely to accommodate for the high membrane demand. Biogenesis of large communal PVs involves homotypic fusion between smaller PVs (Fig 2) [22], which may rely on the hijacking of specific components of the membrane fusion machinery. In support of this model, targeting the ERGIC (ER-Golgi intermediate compartment) Q-SNARE Stx5 or the ER R-SNARE Sec22b and its cognate Q-SNARE partners Stx18 and D12 restricts the expansion of L. amazonensis PVs and is detrimental to parasite replication [24]. Whether the molecular basis for this fundamental difference in the lifestyle of these two groups of Leishmania is related to differential expression or activity of virulence factors such as GP63 that directly target specific components of the host cell machinery remains to be investigated.
Fig 2

Two communal vacuoles undergoing homotypic fusion.

Murine primary macrophages were infected for three days with carboxyfluorescein succinimidyl ester (CFSE)-stained L. amazonensis parasites (green) and then monitored every two minutes by live-cell imaging. Arrowheads point to the septum between two parasitophorous vacuoles throughout the fusion process. Scale bar = 5 μm.

Two communal vacuoles undergoing homotypic fusion.

Murine primary macrophages were infected for three days with carboxyfluorescein succinimidyl ester (CFSE)-stained L. amazonensis parasites (green) and then monitored every two minutes by live-cell imaging. Arrowheads point to the septum between two parasitophorous vacuoles throughout the fusion process. Scale bar = 5 μm.

Conclusion

As our understanding of the function of membrane fusion mediators deepens, we are able to get a better insight into the challenges faced by Leishmania parasites upon entry into host cells and, in parallel, the mechanisms of parasite virulence and pathogenesis. Conversely, Leishmania represents a superb tool for the identification of novel roles for the membrane fusion machinery in macrophages, by investigating the functional consequences of host protein cleavage or intracellular redistribution on cell and immune functions. Components of the membrane fusion machinery might emerge as targets for novel therapeutic interventions in infectious and inflammatory diseases.
  24 in total

Review 1.  Botulinum neurotoxin: a marvel of protein design.

Authors:  Mauricio Montal
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

2.  Disruption of the fusion of Leishmania parasitophorous vacuoles with ER vesicles results in the control of the infection.

Authors:  Johnathan Canton; Blaise Ndjamen; Kiyotaka Hatsuzawa; Peter E Kima
Journal:  Cell Microbiol       Date:  2012-02-24       Impact factor: 3.715

Review 3.  Fusion, fission, and secretion during phagocytosis.

Authors:  Kassidy K Huynh; Jason G Kay; Jennifer L Stow; Sergio Grinstein
Journal:  Physiology (Bethesda)       Date:  2007-12

4.  Synaptotagmin XI regulates phagocytosis and cytokine secretion in macrophages.

Authors:  Guillermo Arango Duque; Mitsunori Fukuda; Albert Descoteaux
Journal:  J Immunol       Date:  2013-01-09       Impact factor: 5.422

5.  Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8.

Authors:  Diana Matheoud; Neda Moradin; Angélique Bellemare-Pelletier; Marina Tiemi Shio; Wan Jin Hong; Martin Olivier; Etienne Gagnon; Michel Desjardins; Albert Descoteaux
Journal:  Cell Host Microbe       Date:  2013-07-17       Impact factor: 21.023

6.  Ca2+ and synaptotagmin VII-dependent delivery of lysosomal membrane to nascent phagosomes.

Authors:  Cecilia Czibener; Nathan M Sherer; Steven M Becker; Marc Pypaert; Enfu Hui; Edwin R Chapman; Walther Mothes; Norma W Andrews
Journal:  J Cell Biol       Date:  2006-09-18       Impact factor: 10.539

7.  Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures.

Authors:  Maria Cecilia Fernandes; Laura A L Dillon; Ashton Trey Belew; Hector Corrada Bravo; David M Mosser; Najib M El-Sayed
Journal:  mBio       Date:  2016-05-10       Impact factor: 7.867

8.  The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V.

Authors:  Adrien F Vinet; Mitsunori Fukuda; Salvatore J Turco; Albert Descoteaux
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

9.  The SNARE protein family of Leishmania major.

Authors:  Sébastien Besteiro; Graham H Coombs; Jeremy C Mottram
Journal:  BMC Genomics       Date:  2006-10-06       Impact factor: 3.969

10.  Leishmania major Promastigotes Evade LC3-Associated Phagocytosis through the Action of GP63.

Authors:  Christine Matte; Pierre-André Casgrain; Olivier Séguin; Neda Moradin; Wan Jin Hong; Albert Descoteaux
Journal:  PLoS Pathog       Date:  2016-06-09       Impact factor: 6.823

View more
  12 in total

1.  Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.

Authors:  M Van den Kerkhof; L Van Bockstal; J F Gielis; P Delputte; P Cos; L Maes; Guy Caljon; Sarah Hendrickx
Journal:  Parasitol Res       Date:  2018-08-23       Impact factor: 2.289

2.  VAMP3 and VAMP8 Regulate the Development and Functionality of Parasitophorous Vacuoles Housing Leishmania amazonensis.

Authors:  Olivier Séguin; Linh Thuy Mai; Hamlet Acevedo Ospina; Marie-Michèle Guay-Vincent; Sidney W Whiteheart; Simona Stäger; Albert Descoteaux
Journal:  Infect Immun       Date:  2022-02-07       Impact factor: 3.609

3.  Revisiting the Principles of Designing a Vaccine.

Authors:  Shubhranshu Zutshi; Sunil Kumar; Prashant Chauhan; Bhaskar Saha
Journal:  Methods Mol Biol       Date:  2022

4.  Leishmania donovani Metacyclic Promastigotes Impair Phagosome Properties in Inflammatory Monocytes.

Authors:  Christine Matte; Guillermo Arango Duque; Albert Descoteaux
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

5.  RNA-Seq Revealed Expression of Many Novel Genes Associated With Leishmania donovani Persistence and Clearance in the Host Macrophage.

Authors:  Mohammad Shadab; Sonali Das; Anindyajit Banerjee; Roma Sinha; Mohammad Asad; Mohd Kamran; Mithun Maji; Baijayanti Jha; Makaraju Deepthi; Manoharan Kumar; Abhishek Tripathi; Bipin Kumar; Saikat Chakrabarti; Nahid Ali
Journal:  Front Cell Infect Microbiol       Date:  2019-02-05       Impact factor: 5.293

6.  Leishmania braziliensis: Strain-Specific Modulation of Phagosome Maturation.

Authors:  Tamara da Silva Vieira; Guillermo Arango Duque; Kévin Ory; Celia Maria Gontijo; Rodrigo Pedro Soares; Albert Descoteaux
Journal:  Front Cell Infect Microbiol       Date:  2019-09-06       Impact factor: 5.293

7.  The host cell secretory pathway mediates the export of Leishmania virulence factors out of the parasitophorous vacuole.

Authors:  Guillermo Arango Duque; Armando Jardim; Étienne Gagnon; Mitsunori Fukuda; Albert Descoteaux
Journal:  PLoS Pathog       Date:  2019-07-29       Impact factor: 6.823

8.  Leishmania Lipophosphoglycan Triggers Caspase-11 and the Non-canonical Activation of the NLRP3 Inflammasome.

Authors:  Renan V H de Carvalho; Warrison A Andrade; Djalma S Lima-Junior; Marisa Dilucca; Caroline V de Oliveira; Kun Wang; Paula M Nogueira; Jeronimo N Rugani; Rodrigo P Soares; Stephen M Beverley; Feng Shao; Dario S Zamboni
Journal:  Cell Rep       Date:  2019-01-08       Impact factor: 9.423

9.  Complement receptor 3 mediates ruffle-like, actin-rich aggregates during phagocytosis of Leishmania infantum metacyclics.

Authors:  Upasna Gaur Dixit; Nilda E Rodríguez; Rachel Polando; Mary Ann McDowell; Mary E Wilson
Journal:  Exp Parasitol       Date:  2020-08-08       Impact factor: 2.011

10.  Genome-wide association meta-analysis of coronary artery disease and periodontitis reveals a novel shared risk locus.

Authors:  Matthias Munz; Gesa M Richter; Bruno G Loos; Søren Jepsen; Kimon Divaris; Steven Offenbacher; Alexander Teumer; Birte Holtfreter; Thomas Kocher; Corinna Bruckmann; Yvonne Jockel-Schneider; Christian Graetz; Loreto Munoz; Anita Bhandari; Stephanie Tennstedt; Ingmar Staufenbiel; Nathalie van der Velde; André G Uitterlinden; Lisette C P G M de Groot; Jürgen Wellmann; Klaus Berger; Bastian Krone; Per Hoffmann; Matthias Laudes; Wolfgang Lieb; Andre Franke; Henrik Dommisch; Jeanette Erdmann; Arne S Schaefer
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.